Tolerance Bio
Philadelphia
About Tolerance Bio
Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases thymus.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $20.2M
- Funding stage: Seed
- Last round: Seed (Oct 2024)
- Website: tolerancebio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/tolerance-bio-14678 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.